Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 69 results found. Search for [ cipla cancer drug ]

Results 1 to 21 of 69
PTI
March 2, 2021
The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray


BusinessToday.In
October 16, 2020
India Stock Market Highlights Today: IndusInd Bank, Tata Steel, Infosys, ONGC, BPCL, Cipla, Kotak Bank, NTPC and Bharti Airtel were among prominent gainers. On the other hand, Asian Paints, Sun Pharma, Nestle, RIL, M&M, HCL Tech were among the top losers.


PB Jayakumar
September 11, 2020
\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper


BusinessToday.In
August 12, 2020
Stocks to watch today on August 12: HDFC, Eicher Motors, Dr Reddy, Adani Ports, JMC Projects among others are the top stocks to watch out for in Wednesday's trading session.


BusinessToday.In
July 27, 2020
Avra Lab has developed an alternative low-cost and highly efficient manufacturing process and is now supplying commercial quantities to Cipla for the launch of Ciplenza, the generic version of Favipiravir


Joe C Mathew
New Delhi, April 18, 2020
Coronavirus news: Indian Council of Medical Research (ICMR) had hinted that if the medicine proves effective, and if cost effective versions of the medicine can be made available through Indian generic companies, then it can be considered for treating COVID-19 patients in India


BusinessToday.In
April 8, 2020
Sensex, Nifty Live News Today:  FTSE and CAC  in Europe fell over 1%, followed 0.50% decline in DAX. SGX Nifty was also trading 1% lower, while Dow Jones Futures traded flat.


PB Jayakumar
January 16, 2020
Wockhardt latest medicines: Wockhardt announces two new drugs for skin infections, its shares rise by 14 per cent intraday. Here's what this means


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


PTI
September 2, 2019



E Kumar Sharma
New Delhi, July 18, 2018
Those within the pharma industry see a couple of messages coming across from the movie.


PB Jayakumar
August 12, 2016
The company has appointed Umang Vohra, currently the Global Chief Financial and Strategy Officer, as the Managing Director and  Global CEO since September 1.


By E. Kumar Sharma
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


BT Online
New Delhi, July 11, 2016
Shares of  Tata Motors settled the day 4.15 per cent up on BSE after the company reported 20.8 per cent increase in global sales at 92,551 units, including that of Jaguar Land Rover (JLR) vehicles, in June.


E Kumar Sharma
July 11, 2016
India's leading pharma company Cipla has announced that \"proposed biotech subsidiary in South Africa will invest over 1.3 billion rand into the country's first state-of-the-art biotech manufacturing facility, for the production of biosimilars.\"


PTI
New Delhi, June 6, 2016
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.


P.B. Jayakumar and E. Kumar Sharma
Delhi, January 16, 2016
Since the past eight months the merged entity has been trading on the Bombay Stock Exchange, nervous investors have been asking two questions - is Shangvi's magic fading? Or, is the slump just a small hitch in Sun's glorious journey over the past one decade?


Pritam Pal Singh and Hary M Pillai
New Delhi, January 2, 2016
The Delhi High Court in 2015 also rapped the Centre for its coal auction ordinance by saying that the legislation \"lacked clarity\".


E Kumar Sharma
December 18, 2015
Till end of November, over 170 inspections were held in India as against over 70 inspection and certainly much less than 100 conducted five years ago by the US regulator in India.


PTI
New Delhi, August 27, 2015
In a statement, drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) said, \"It has fixed/revised the prices in respect of 39 formulation packs ... and one corrigendum ... related to the ceiling price fixation of Paclitaxel injection.\"


PAGES 1 OF 4  1234